Arkolith/Insider Trading/NVCT/Form 4/A

Mosseri Marlio Charles

10% OwnerNuvectis Pharma, Inc. (NVCT) · full profile →Form 4/A · filed Dec 16, 2024
Net Buying
Open-Market Buys
$229K
Open-Market Sells
$0
Net Open-Market Flow
$229K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2024Buy(P)17K$4.70$80K2.6M
Dec 12, 2024Buy(P)32K$4.64$149K2.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-24-129009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML